It is early in the morning and I am poking around in my email looking for interesting items on health and medicine search. I am finding that calls for papers for conferences or announcements of competitions in various areas of biomedicine are actually quite interesting and lead to enjoyable and productive hours of surfing and fruitful moments of serendipity. One such case is an email notice I got a few days ago from the magazine Bio-IT World that mentioned its competition, Bio-IT World Best Practices: 2009 Call for Entries:

Reading the come-on to prospective entrants provides some insight into the pressures biotech and pharma generally are facing these days to impress potential investors, analysts and the scientific community (from whence comes the brainpower it needs for survival’s sake):

“Take advantage of this opportunity to showcase your organization’s efforts and talents, and contribute to the industry’s broader knowledge base.

EARLY BIRD DEADLINE (No Fee): December 18, 2008
FINAL DEADLINE FOR ENTRIES: January 21, 2009

Benefits of participation:

* Gain Peer Recognition: Spotlight the talent of your team, and position your organization as a thought leader, among an elite group of life science professionals.
* Heighten Visibility: Use creative positioning to add another layer of credibility in the industry. Entries, nominees and especially winners receive recognition at the Gala Dinner, in widely-distributed press releases, in the Best Practices issue of Bio-IT World magazine, as well as continued coverage on Bio-ITWorld.com and in the Best Practices Compendium of entries.
* Leverage Exposure: Showcase your expertise and unique solutions, and use the exposure as a conduit to valuable connections, investors, sales leads, job candidates, and other external audiences.

Well, it is working with me so far!! I get the magazine and there is always something interesting about how modern science is conducted and the results disseminated.

It was interesting to read what fields are covered in competition:

* Basic Research & Biological Research: Disease pathway research, applied and basic research
* Drug Discovery & Development: Compound-focused research, drug safety
* Clinical Trials & Research: Trial design, eCTD
* Translational Medicine: Feedback loops, predictive technologies
* Personalized Medicine: Responders/non-responders, biomarkers
* IT & Informatics: LIMS, High Performance Computing, storage, data visualization, imaging technologies
* Knowledge Management: Data mining, idea/expertise mining, text mining, collaboration, resource optimization
* Health-IT: ePrescribing, RHIOs, EMR/PHR
* Manufacturing & Bioprocessing: Mass production, continuous manufacturing

I decided to take a look at what was showcased in 2008 and perusing many of the articles linked to is a good way to see how big pharma and big government science are adapting to the world of Science 2.0.

Here is an interesting article for example: Connecting the Cancer Community caBIG Time

Now this is an ambitious undertaking that I had not heard about before. Here is some of what I read here:

caBIG™ stands for the cancer Biomedical Informatics Grid™. caBIG™ is an information network enabling all constituencies in the cancer community – researchers, physicians, and patients – to share data and knowledge. The components of caBIG™ are widely applicable beyond cancer as well.

The mission of caBIG™ is to develop a truly collaborative information network that accelerates the discovery of new approaches for the detection, diagnosis, treatment, and prevention of cancer, ultimately improving patient outcomes.

The goals of caBIG™ are to:

* Connect scientists and practitioners through a shareable and interoperable infrastructure
* Develop standard rules and a common language to more easily share information
* Build or adapt tools for collecting, analyzing, integrating, and disseminating information associated with cancer research and care.

Since its inception, caBIG™ has committed to the following cornerstones:

* Federated: caBIG™ software and resources are widely distributed, interlinked, and available to everyone in the cancer research community, but institutions maintain local control over their own resources and data.
* Open-development: caBIG™ tools and infrastructure are being developed through an open, participatory process. caBIG™ leverages existing resources whenever possible, rather than building new tools in every case.
* Open-access:caBIG™ resources are freely obtainable by the cancer community to ensure broad data-sharing and collaboration.
* Open-source: The caBIG™ source code is available to view, alter, and redistribute.

Whoa! That is a pretty sweeping mandate and game plan! This is one heck of a gargantuan undertaking, but when you read about the dynamo behind it and look at how far it has come in a few years you start to have real faith in big government science and realize that within massive research organizations there are some damn impressive people who want to take a machete to stultifying processes and stodgy mindsets that have unnecessarily impeded scientific progress for too long. One such intellectual powerhouse is profiled thus:

Kenneth H. Buetow, Ph.D., is the National Cancer Institute (NCI) Associate Director for Bioinformatics and Information Technology and the Director of the NCI Center for Bioinformatics (NCICB). As Director of the NCICB, Dr. Buetow oversees coordination and deployment of informatics in support of NCI research initiatives and the Center’s participation in the evaluation and prioritization of the NCI’s biomedical informatics research portfolio. Dr. Buetow initiated the cancer Biomedical Informatics Grid™ (caBIG™) pilot project and oversees its activities.

Go, Dr. Buetow, go! Keep the good work! The hope, apparently, is to create a model in the case of cancer that will engender like networks throughout medicine. A worthy, noble goal.

By contrast, to the culture of openness Dr. Buetow exemplifies here is a case of really bad marketing. As I write this column, I am clicking around some of the links in the original Bio-IT World article. I wanted to see to check out what sorts of conferences were advertised for those in the biomedical field. I was rather intrigued by the idea of writing here about the 4th Annual World Healthcare Innovation and Technology Congress. But to get a brochure, you have to register — give me a break! How lame is that?

And then to compound the image of troglodyte thinking and the utter incapacity to grasp the revolution that is Web 2.0 that healthcare IT already has in the rest of the tech world, here is the wording on the press page.

“World Congress press credentials are available to full-time editorial staff writers employed by a trade publication, mainstream media outlet (newspaper, radio, TV, etc.), or online magazines. Freelance writers or contributing editors may request press credentials if the event is being covered for a specific publication.”

Grrrrrrrr. That pretty much excludes tech bloggers who produce some of the best coverage of IT around. If I were in charge of a major tech conference, I would not hire Patrick Golden to be my director of communications. But then I am just a little tech blogger and he has bigger fish to fry. But dissing the tech blogosphere is not the act of a smart person in the age of Web 2.0. No wonder the bright young minds of tech give healthcare a pass so very often–much to my continuing dismay, as someone who works in healthcare.

This entry was posted on Monday, December 1st, 2008 at 2:31 pm and is filed under Health, Reviews, Verticals. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.